HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...
Study comparing BioStem’s proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinical efficacy to support market expansion ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
Migration of Institutional Review Board (IRB) activities to the Purdue Excellence in Research Administration (PERA) platform is underway. The PERA-IRB module will go live Monday (Oct. 27). With the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results